【2h】

Short constrained peptides that inhibit HIV-1 entry

机译:抑制HIV-1进入的短约束肽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peptides corresponding to the C-terminal heptad repeat of HIV-1 gp41 (C-peptides) are potent inhibitors of HIV-1 entry into cells. Their mechanism of inhibition involves binding in a helical conformation to the central coiled coil of HIV-1 gp41 in a dominant–negative manner. Short C-peptides, however, have low binding affinity for gp41 and poor inhibitory activity, which creates an obstacle to the development of small drug-like C-peptides. To improve the inhibitory potency of short C-peptides that target the hydrophobic pocket region of gp41, we use two strategies to stabilize the C-peptide helix: chemical crosslinking and substitution with unnatural helix-favoring amino acids. In this study, the short linear peptide shows no significant inhibitory activity, but a constrained peptide (C14linkmid) inhibits cell–cell fusion at micromolar potency. Structural studies confirm that the constrained peptides bind to the gp41 hydrophobic pocket. Calorimetry reveals that, of the peptides analyzed, the most potent are those that best balance the changes in binding enthalpy and entropy, and surprisingly not those with the highest helical propensity as measured by circular dichroism spectroscopy. Our study reveals the thermodynamic basis of inhibition of an HIV C-peptide, demonstrates the utility of constraining methods for a short antiviral peptide inhibitor, and has implications for the future design of constrained peptides.
机译:对应于HIV-1 gp41的C端七肽重复序列的肽(C肽)是HIV-1进入细胞的有效抑制剂。他们的抑制机制包括以显性-阴性方式以螺旋构象结合至HIV-1 gp41的中央螺旋状螺旋。但是,短的C肽对gp41的结合亲和力很低,抑制活性很差,这阻碍了小药物样C肽的发展。为了提高靶向gp41疏水口袋区域的短C肽的抑制能力,我们使用两种策略来稳定C肽的螺旋结构:化学交联和用非天然螺旋结构有利的氨基酸取代。在这项研究中,短线性肽没有显示出明显的抑制活性,但约束肽(C14linkmid)以微摩尔效价抑制细胞间融合。结构研究证实,受约束的肽与gp41疏水袋结合。量热法显示,在所分析的肽中,最有效的肽是能最平衡结合焓和熵的变化的肽,而令人惊讶的是,不是用圆二色性光谱法测得的具有最高螺旋倾向的肽。我们的研究揭示了抑制HIV C肽的热力学基础,证明了短抗病毒肽抑制剂的约束方法的实用性,并对约束肽的未来设计具有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号